Skip to content
PubMed This is a summary of 97 peer-reviewed journal articles Updated
Ophthalmology · Wet age-related macular degeneration

Wet Macular Degeneration: A Patient Guide

At a Glance

Wet macular degeneration can change central vision quickly when fragile blood vessels leak beneath the retina. Prompt injections that block abnormal vessel growth and regular scans can often stabilize vision and limit further damage, although established scarring or tissue loss may not be reversible.

Wet age-related macular degeneration (wet AMD) is a condition that occurs when the body’s age-related retinal and choroidal changes, combined with an imbalance of inflammatory and angiogenic signals, lead to the growth of abnormal, fragile blood vessels beneath the retina. These new vessels are prone to leaking fluid and blood into the macula, the specialized part of the eye responsible for the sharp, central vision you use for reading, driving, and recognizing faces [1]. While this process can lead to rapid changes in your sight, the defining characteristic of modern wet AMD care is that it is highly treatable. With prompt medical intervention, many patients are able to stabilize their vision, reduce leakage, and lower the risk of further vision loss, though treatment may only stabilize vision and cannot reliably reverse established scar or atrophy [2].

The standard of care for managing this condition involves regular injections of medications known as anti-VEGF agents. These treatments work by blocking the specific protein that signals these leaky vessels to grow, effectively “drying out” the retina and preventing further damage to the delicate light-sensing cells [3]. Because the underlying tendency to grow these vessels remains, wet AMD is managed as a chronic condition rather than a one-time event. This means that long-term success depends heavily on adherence to an individualized, scheduled regimen of monitoring and treatment. Even when your vision feels stable, regular scans are essential because they allow your specialist to detect and treat microscopic leaks before they cause permanent scarring [4][5].

Living with wet AMD requires a partnership between you and your clinical team, centered on vigilance and rapid communication. It is completely normal to feel anxious about injections or fearful of vision loss. The most critical moments in your care often happen at home, where noticing a new waviness in straight lines or a sudden “smudge” in the center of your gaze serves as an early warning system. By responding immediately to these changes and maintaining your appointment schedule, you can take control of the disease’s progression. While the diagnosis marks a significant change, the availability of advanced therapies means that preserving your visual function is a realistic goal [2][6].


Urgent Symptoms Action Box
If you experience any of the following, do not wait for your next appointment. Seek same-day advice from your eye team or emergency care if the clinic cannot be reached:

  • New distortion or wavy lines
  • A new central blur or blind spot
  • Sudden vision loss
  • New flashes of light or a sudden shower of floaters
  • A dark curtain or shadow moving across your vision

If You Miss or Cannot Afford an Appointment:
We understand that the treatment burden is high and transportation or cost barriers happen. A missed appointment does not automatically mean irreversible blindness, but do not simply wait for the next month. Contact your clinic as soon as possible to reschedule and ask to speak with a social worker about transportation or financial assistance.

Common questions in this guide

What is wet macular degeneration?
Wet macular degeneration occurs when fragile abnormal blood vessels grow beneath the retina and leak fluid or blood into the macula, the area responsible for sharp central vision. It can change vision quickly, but prompt and ongoing treatment can often stabilize sight and reduce further damage.
How do anti-VEGF injections treat wet AMD?
Anti-VEGF medicines block a growth signal that causes abnormal blood vessels to grow and leak. Injections into the eye can reduce leakage and help protect the retina, but treatment usually needs to be repeated according to your eye specialist’s plan.
Why do I need scans if my vision feels stable?
Wet AMD can have small leaks before you notice a change in vision. Regular scans help your eye team find activity early and adjust treatment before more permanent damage occurs.
Which vision changes need same-day medical attention?
Contact your eye team the same day for new wavy lines, central blur or a blind spot, or sudden vision loss. New flashes, a sudden shower of floaters, or a dark curtain or shadow across your vision also require urgent advice or emergency care if your clinic cannot be reached.
How often will I need treatment for wet AMD?
There is no single schedule for everyone because treatment depends on your vision and what the scans show. Wet AMD is chronic, so many people need ongoing injections and monitoring even when their sight feels stable.
What should I do if I miss or cannot afford an appointment?
Contact your clinic as soon as possible rather than waiting for the next scheduled month, and ask to reschedule. Ask whether a social worker can help with transportation or financial assistance.
Can wet AMD treatment restore vision that I have already lost?
Treatment often helps stabilize vision, reduce leakage, and lower the risk of additional loss. It cannot reliably reverse damage from established scarring or tissue loss, so early treatment and keeping appointments are important.

Get notified when new evidence is published on wet macular degeneration.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    Macular neovascularization.

    Sheth JU, Stewart MW, Narayanan R, et al.

    Survey of ophthalmology 2025; (70(4)):653-675 doi:10.1016/j.survophthal.2024.08.003.

    PMID: 39222802
  2. 2

    Novel approach to antiangiogenic factors in age-related macular degeneration therapy.

    Samelska K, Kupis M, Izdebska J, et al.

    Central-European journal of immunology 2022; (47(1)):117-123 doi:10.5114/ceji.2022.113103.

    PMID: 35600160
  3. 3

    Efficacy and Safety of Anti-Vascular Endothelial Growth Factor Monotherapies for Neovascular Age-Related Macular Degeneration: A Mixed Treatment Comparison.

    Zhang Y, Gao S, Li X, et al.

    Frontiers in pharmacology 2021; (12()):797108 doi:10.3389/fphar.2021.797108.

    PMID: 34992542
  4. 4

    Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial.

    Ramakrishnan MS, Yu Y, VanderBeek BL

    JAMA ophthalmology 2020; (138(3)):237-242 doi:10.1001/jamaophthalmol.2019.4577.

    PMID: 32027349
  5. 5

    Reactivation of stable neovascular age-related macular degeneration following treat-and-extend regimen discontinuation.

    Artiaga JCM, Wong SW, Menon D, et al.

    Clinical & experimental ophthalmology 2025; (53(1)):76-83 doi:10.1111/ceo.14444.

    PMID: 39354837
  6. 6

    Optical Coherence Tomography-Angiography of Different Choroidal Neovascularization Subtypes in Wet Age-related Macular Degeneration.

    Stavrev VN, Sivkova NP, Koleva-Georgieva DN

    Folia medica 2019; (61(2)):317-326.

    PMID: 31301657

This page is for informational purposes only and does not constitute medical advice. Your eye-care team should interpret your scans and advise you about injections or urgent vision changes.